Metformin Attenuates TGF-β1-Induced Fibrosis in Salivary Gland: A Preliminary Study
International Journal of Molecular Sciences · 13.11.2023 · 24 (22) · 16260
DOI: 10.3390/ijms242216260 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.11.2023. Verfasst von Lianhao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Fibrosis commonly arises from salivary gland injuries induced by factors such as inflammation, ductal obstruction, radiation, aging, and autoimmunity, leading to glandular atrophy and functional impairment. However, effective treatments for these injuries remain elusive. Transforming growth factor-beta 1 (TGF-β1) is fundamental in fibrosis, advancing fibroblast differentiation into myofibroblasts and enhancing the extracellular matrix in the salivary gland. The involvement of the SMAD pathway and reactive oxygen species (ROS) in this context has been postulated. Metformin, a type 2 diabetes mellitus (T2DM) medication, has been noted for its potent anti-fibrotic effects. Through human samples, primary salivary gland fibroblasts, and a rat model, this study explored metformin’s anti-fibrotic properties. Elevated levels of TGF-β1 (p < 0.01) and alpha-smooth muscle actin (α-SMA) (p < 0.01) were observed in human sialadenitis samples. The analysis showed that metformin attenuates TGF-β1-induced fibrosis by inhibiting SMAD phosphorylation (p < 0.01) through adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK)-independent pathways and activating the AMPK pathway, consequently suppressing NADPH oxidase 4 (NOX4) (p < 0.01), a main ROS producer. Moreover, in rats, metformin not only reduced glandular fibrosis post-ductal ligation but also protected acinar cells from ligation-induced injuries, thereby normalizing the levels of aquaporin 5 (AQP5) (p < 0.05). Overall, this study underscores the potential of metformin as a promising therapeutic option for salivary gland fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
- Department of Oral Radiology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.
ORCID-Profile: Yuhong Li
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation of China
Zitieren
APA
Wang, L., Zhong, N. N., Wang, X., Peng, B., Chen, Z., Wei, L., Li, B., Li, Y., & Cheng, Y. (2023). Metformin Attenuates TGF-β1-Induced Fibrosis in Salivary Gland: A Preliminary Study. International Journal of Molecular Sciences, 24(22), 16260. https://doi.org/10.3390/ijms242216260
Vancouver
Wang L, Zhong NN, Wang X, Peng B, Chen Z, Wei L, et al. Metformin Attenuates TGF-β1-Induced Fibrosis in Salivary Gland: A Preliminary Study. International Journal of Molecular Sciences. 2023;24(22):16260. doi:10.3390/ijms242216260
BibTeX
@article{Wang2023,
author = {Wang, Lianhao and Zhong, Nian-Nian and Wang, Xiaofeng and Peng, Boyuan and Chen, Zhuo and Wei, Lili and Li, Bo and Li, Yuhong and Cheng, Yong},
title = {Metformin Attenuates TGF-β1-Induced Fibrosis in Salivary Gland: A Preliminary Study},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {22},
pages = {16260},
doi = {10.3390/ijms242216260}
}
EUVIMED